97 related articles for article (PubMed ID: 79863)
1. Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women.
Tikkanen MJ; Nikkila EA; Vartiainen E
Lancet; 1978 Sep; 2(8088):490-1. PubMed ID: 79863
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
3. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Report from the Medications Working Group of the Lipid Research Clinics Program.
Wallace RB; Hoover J; Barrett-Connor E; Rifkind BM; Hunninghake DB; Mackenthun A; Heiss G
Lancet; 1979 Jul; 2(8134):112-5. PubMed ID: 88553
[TBL] [Abstract][Full Text] [Related]
4. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
Olsson AG; Lang PD
Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175
[TBL] [Abstract][Full Text] [Related]
5. Lipoproteins during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
Fåhraeus L; Larsson-Cohn U; Wallentin L
Acta Endocrinol (Copenh); 1982 Dec; 101(4):597-602. PubMed ID: 7158232
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
Vessby B; Hedstrand H; Olsson U
Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
8. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
[TBL] [Abstract][Full Text] [Related]
9. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.
Olsson AG; Lang PD
Atherosclerosis; 1978 Dec; 31(4):421-8. PubMed ID: 215174
[TBL] [Abstract][Full Text] [Related]
10. Changes in lipoproteins and subfractions following oophorectomy and oestrogen replacement in peri-menopausal women.
Blumenfeld Z; Aviram M; Brook GJ; Brandes JM
Maturitas; 1983 Aug; 5(2):77-83. PubMed ID: 6579340
[TBL] [Abstract][Full Text] [Related]
11. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
Carlson LA; Olsson G; Ballantyne D
Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526
[TBL] [Abstract][Full Text] [Related]
12. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
Christiansen C; Christensen MS; Grande P; Transbøl I
Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
[TBL] [Abstract][Full Text] [Related]
13. Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet.
Vessby B; Carlson LA
Eur J Clin Invest; 1975 Jul; 5(4):359-64. PubMed ID: 170119
[TBL] [Abstract][Full Text] [Related]
14. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
Olsson AG; Rössner S; Walldius G; Carlson LA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
[TBL] [Abstract][Full Text] [Related]
15. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
16. Normal serum-cholesterol but low H.D.L.-cholesterol concentration in young patients with ischaemic cerebrovascular disease.
Rössner S; Kjellin KG; Mettinger KL; Sidén A; Söderström CE
Lancet; 1978 Mar; 1(8064):577-9. PubMed ID: 76122
[TBL] [Abstract][Full Text] [Related]
17. Acute effect of dietary therapy of type IV hyperlipoproteinaemia on the serum and lipoprotein concentrations and relative composition.
Ballantyne D; Olsson AG; Carlson LA
Atherosclerosis; 1978 May; 30(1):79-87. PubMed ID: 209798
[TBL] [Abstract][Full Text] [Related]
18. The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women.
Farish E; Fletcher CD; Hart DM; Azzawi FA; Abdalla HI; Gray CE
Acta Endocrinol (Copenh); 1984 May; 106(1):116-20. PubMed ID: 6730851
[TBL] [Abstract][Full Text] [Related]
19. Composition of low-density lipoprotein in children with hyperlipoproteinaemia.
Bagnall TF; Lloyrd JK
Clin Chim Acta; 1975 Mar; 59(3):271-6. PubMed ID: 165017
[TBL] [Abstract][Full Text] [Related]
20. Plasma-triglycerides in regulation of H.D.L.-cholesterol levels.
Schaefer EJ; Levy RI; Anderson DW; Danner RN; Brewer HB; Blackwelder WC
Lancet; 1978 Aug; 2(8086):391-3. PubMed ID: 79759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
